Paul Anderson, Managing Director
Paul has over 16 years’ experience in the medical device and cell therapy fields, with expertise in bridging the gap between research and clinical practice in the development of emerging medical technologies. This experience encompasses applying a regulatory framework to the product and the accompanying ‘grey area’ interpretation, rebating pathways, marketing, sales, developing clinical relationships, strategic and financial planning. Paul’s strong track record includes his previous board position with Verigen Australia, a human cell therapies company.
Professor M.H. Zheng, Chief Scientific Officer
Professor Zheng is inventor of Orthocell’s technology and brings a strong track record of innovation to the company. He completed his PhD in 1993 and Doctor of Medicine (DM) in 1998 at the University of Western Australia and is a Fellow of the Royal College of Pathologists. Currently, Prof Zheng is the Director of Research in the Department of Orthopaedic Surgery at the University of Western Australia. His research focus involves using cutting-edge cellular and molecular biology technique to discover new ways to treat osteoporosis, osteoarthritis and tendon injuries.
Nicole Telford, Chief Financial Officer
Nicole is a chartered accountant and has over 14 years’ commercial experience in financial controller/group accountant roles. Nicole’s achieved her professional qualifications while employed at Arthur Andersen in the audit division, providing her with a broad range of experience. She has commercial experience in financial and management reporting, office administration and staff management.
Alex McHenry, Chief Operating Officer
Alex has over 17 years of experience in corporate advisory and management consulting, with a particular focus on the execution of corporate strategy, capital raising and business transformation initiatives in the biotechnology and resources industry. Alex started his career with Arthur Anderson, assisting clients with business transformation strategy and implementation of operational improvement programs. Prior to joining Orthocell, Alex worked as a corporate consultant, working with his clients in the execution and financing of asset acquisitions and in the management of development programs in the biotechnology and mining sectors in Australia and SE Asia.